Abstract Library

#4352 What can a reference centre offer to patients? Evolution of first visits for neuroendocrine and endocrine tumours and its relation to clinical trials availability.

Introduction: Endocrine and neuroendocrine neoplasia (NEN), which include gastroenteropancreatic neuroendocrine tumours, thyroid cancer and adrenal carcinoma, have a low incidence, making their diagnosis and treatment difficult. Due to this complexity, patients should be managed at specialised centres; however, the lack of official referral networks complicates the concentration of cases.

Conference:

Presenting Author: Martinez-Badal S

Authors: Martínez-Badal S, Hernando Cubero J, García Alvarez A, Elguero B, Alcantara A,

Keywords: Neuroendocrine, Clinical Trial, Reference Centre, Patient referral,

#3149 Nutritional assessment for predicting clinical evolution in gastro-enteropancreatic neuroendocrine tumors

Introduction: Patients with neuroendocrine tumors (NETs) might present with malnutrition due to the tumor itself and/or its treatment. Poor nutritional status and weight loss can lead to poor outcomes, including decreased quality of life, increased complication rates and mortality. Furthermore, the impact of body mass index (BMI) as a relevant risk factor for NETs development is currently a very debated topic as data regarding nutritional status in NETs patients are very limited.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Alzás-Teomiro C, León-Idougourram S, Alcántara-Laguna M, Molina-Puertas M, Gálvez-Moreno M,

Keywords: neuroendocrine, GEP, nutrition,